BioPortfolio Blog about Biotechnology, Pharmaceutical and Healthcare

23:45 EST 9th February 2016 | BioPortfolio

Updates and info from the contributors bringing you

Showing News Articles 1–5 of 419

Tuesday 9th February 2016

U.S. researchers find new bacteria that causes Lyme disease

A deer tick, or blacklegged tick, Ixodes scapularis, is seen on a blade of grass, in this undated picture from the Centers for Disease Control and Prevention. The Centers for Disease Control and Prevention, working with the Mayo Clinic and health officials from Minnesota, Wisconsin and North Dakota, discovered the new bacteria, called Borrelia mayonii, the CDC said in a statement.

Achillion to Present at the Leerink Partners 5th Annual Global Healthcare Conference

Achillion Pharmaceuticals, Inc. announced today that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at the Leerink Partners 5th Annual Global Healthcare Conference on Thursday, February 11, 2016, at 11:35 a.m. ET at the Waldorf Astoria Hotel in New York, NY. The live audio and subsequent archived webcasts of the Company's presentation...

Press release distribution, EDGAR filing, XBRL, regulatory filings

Throughout the confe... )--Continuum Analytics today announced the release of Anaconda 2.5. The latest version of Anaconda is now coupled with Intel Math Kernel Library optimizat... )--The Board of Directors of Liberty All-Star Growth Fund, Inc. has declared a distribution of $0.08 per share payable on March 28, 2016 to shareholders of record ... )--Macy's has partnered with AwesomenessTV to debut...

Gov't report: 8 states had significant drop in uninsured

In this Nov. 19, 2013, file photo, the Centers for Disease Control and Prevention sign is photographed at the agency's federal headquarters in Atlanta. A new government report on health insurance has implications for the presidential campaign.

Novartis AG (NVS) Position Held by Cubic Asset Management LLC

Cubic Asset Management LLC continued to hold its stake in shares of Novartis AG during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,915 shares of the company's stock at the end of the fourth quarter.

Quick Search